BC
Beijing CorreGene Biotechnology at SITC 2026
Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website
Beijing CorreGene Biotechnology brings 2 presentations to SITC 2026 in Phoenix. Its program centres on platforms for engineering T cell receptors into cancer drugs. It describes antibody-like soluble T cell engagers built on T cell receptors that recognize antigens from inside tumor cells.
| Organization | SITC 2026 Attendance |
|---|---|
BC Beijing CorreGene Biotechnology Beijing, China | |
Poster Fri Nov 6 12:15–1:45pm 5:30–7pm Poster Sat Nov 7 12:30–1:30pm 6:40–8:10pm |
Instantly find 20 buyers from Beijing CorreGene Biotechnology
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction